Your browser doesn't support javascript.
loading
Race, substance use, and evaluation for heart transplantation: Insights from a large urban medical center.
Chuzi, Sarah; Cabrera, Elizabeth; Ilonze, Onyedika; Vela, Alyssa; Pifer, Lindsay; Wu, Tingqing; Baldridge, Abigail S; Harap, Rebecca; Youmans, Quentin; Ghafourian, Kambiz; Tibrewala, Anjan.
Afiliación
  • Chuzi S; Division of Cardiology, Northwestern University Feinberg School of Medicine, Chicago, Illinois. Electronic address: schuzi@nm.org.
  • Cabrera E; Division of Cardiology, Northwestern University Feinberg School of Medicine, Chicago, Illinois.
  • Ilonze O; Division of Cardiovascular Medicine, Krannert Cardiovascular Research Center, Indiana University, Indianapolis, Indiana.
  • Vela A; Division of Cardiac Surgery, Northwestern University Feinberg School of Medicine, Chicago, Illinois.
  • Pifer L; Division of Cardiac Surgery, Northwestern University Feinberg School of Medicine, Chicago, Illinois.
  • Wu T; Bluhm Cardiovascular Institute Clinical Trials Unit, Northwestern University Feinberg School of Medicine, Chicago, Illinois.
  • Baldridge AS; Bluhm Cardiovascular Institute Clinical Trials Unit, Northwestern University Feinberg School of Medicine, Chicago, Illinois.
  • Harap R; Division of Cardiac Surgery, Northwestern University Feinberg School of Medicine, Chicago, Illinois.
  • Youmans Q; Division of Cardiology, Northwestern University Feinberg School of Medicine, Chicago, Illinois.
  • Ghafourian K; Division of Cardiology, Northwestern University Feinberg School of Medicine, Chicago, Illinois.
  • Tibrewala A; Division of Cardiology, Northwestern University Feinberg School of Medicine, Chicago, Illinois.
J Heart Lung Transplant ; 43(9): 1521-1524, 2024 Sep.
Article en En | MEDLINE | ID: mdl-38763406
ABSTRACT
It is unknown whether racial disparities in access to heart transplantation (HT) are amplified when coupled with substance use. We examined patients evaluated for HT over 8 years at an urban transplant center. We evaluated substance use and race/ethnicity as independent and interactive predictors of HT and left ventricular assist device (LVAD) implantation. Of 1,148 patients evaluated for HT, substance use was cited as an ineligibility factor in 151 (13%) patients, 16 (11%) of whom ultimately received HT. Significantly more non-Hispanic Black (NHB) patients were deemed ineligible due to substance use (n = 59, 19%) compared to other races/ethnicities (non-Hispanic white n = 68, 12%; other race/ethnicity n = 24, p = 0.002). No racial differences were observed in the likelihood of HT among patients initially excluded for substances, but more NHB patients ultimately received LVAD than the other racial groups. This study encourages greater awareness of the role of substance use and race in the HT evaluation.
Asunto(s)
Palabras clave

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Corazón Auxiliar / Trasplante de Corazón / Trastornos Relacionados con Sustancias Idioma: En Revista: J Heart Lung Transplant Asunto de la revista: CARDIOLOGIA / TRANSPLANTE Año: 2024 Tipo del documento: Article

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Corazón Auxiliar / Trasplante de Corazón / Trastornos Relacionados con Sustancias Idioma: En Revista: J Heart Lung Transplant Asunto de la revista: CARDIOLOGIA / TRANSPLANTE Año: 2024 Tipo del documento: Article